Investigational New Drug Applications: Five Solutions To Common Problems

There are many pitfalls that come with preparing an Investigational New Drug (IND) application for FDA submission, but with the right plan – and the right partner – there are also plenty of ways to avoid them. The most important strategy? It all comes down to one thing: Always remember to keep your audience – the FDA reviewers – in mind as you write. Following are five actionable steps can help ensure your next IND is a successful one.